Active-ingredient Dossier

Ritonavir

Active-ingredient Dossier for Ritonavir (protease inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.

Brand: KALETRA
Brand: NORVIR
Brand: PAXLOVID
Therapeutic area: Infectious Disease

What is Ritonavir Ritonavir is a protease inhibitor .

Australian brands containing

Ritonavir — NORVIR — PAXLOVID — KALETRA

Therapeutic areas

Ritonavir is registered in Infectious Disease, with 3 brands containing this ingredient .

Sponsor landscape Ritonavir is marketed by 2 sponsors: AbbVie and Pfizer .

PBS and regulatory activity

One brand containing ritonavir has PBS-listed items, with the latest PBS schedule date of 2026-05-01 . The latest PBAC outcome is from 2023-11-01 and the latest AusPAR is from 2024-08-26 .